RET comprehensive analysis

Alphabetical Test listing

RET comprehensive analysis-994

RET comprehensive analysis
Familial Cancer testing
Hereditary Cancer testing
Inherited Cancer testing
Multiple Endocrine Neoplasia, type 2
Genes included: RET

This assay is intended for patients with a history consistent with Multiple Endocrine Neoplasia, type 2.

EDTA whole blood
10 mL
7 mL

Lavender (EDTA), 10mL

ACD whole blood

Yellow ACD (A or B)



Yellow ACD (A or B)


Ambient (preferred) – 60 days

Refrigerated – 60 days

Frozen - NO

Whole blood - 4 weeks
DNA - 8 weeks
  • Frozen specimen
  • Leaking tube
  • Clotted specimen
  • Hemolysis
  • Quantity not sufficient for analysis (QNS)
  • Incorrect anticoagulant
LabCorp (483472): R-NX
As needed
20 - 28 days

The coding region and flanking splice sites are analyzed by NGS (+/-10bp) and deletion/duplication analysis. Exon-level deletions/duplications are assessed by aCGH. Clinically significant findings are confirmed by Sanger sequencing or qPCR. Results are reported using ACMG guidelines and nomenclature recommended by the Human Genome Variation Society (HGVS).


An interpretive report will be included